journal
https://read.qxmd.com/read/36964637/commentary-on-my-personal-experience-of-patient-and-public-involvement-in-the-topsy-trial
#1
LETTER
Margaret Graham, Kirsteen Goodman
No abstract text is available yet for this article.
March 25, 2023: Trials
https://read.qxmd.com/read/36964583/the-integration-of-rapid-qualitative-research-in-clinical-trials-reflections-from-the-ward-based-goal-directed-fluid-therapy-gdft-in-acute-pancreatitis-feasibility-trial
#2
JOURNAL ARTICLE
Cecilia Vindrola-Padros, Farid Froghi, Vignesh Gopalan, Sachan Maruthan, Helder Filipe, Margaret McNeil, Sara Mingo Garcia, Brian Davidson
BACKGROUND: There has been an increase in the integration of qualitative studies in randomised controlled trials. The purpose of this article is to reflect on our experience of carrying out a rapid qualitative study during a feasibility trial of goal-directed fluid therapy (GDFT) in patients with acute pancreatitis, including our sharing of emerging findings and the use of these findings by the trial team. METHODS: The study was designed as a rapid feedback evaluation and combined interviews with staff and patients who took part in the trial...
March 25, 2023: Trials
https://read.qxmd.com/read/36964626/serial-prophylactic-exchange-blood-transfusion-in-pregnant-women-with-sickle-cell-disease-taps-2-statistical-and-qualitative-analysis-plan-for-a-randomised-controlled-feasibility-trial
#3
JOURNAL ARTICLE
Paul T Seed, Sarah B Brien, Laura L Oakley, Vicky Robinson, Joseph Sharif, Hilary Thompson, Jeannine Joseph, Eugene Oteng-Ntim
BACKGROUND: There are significant knowledge gaps regarding the effectiveness of serial prophylactic exchange blood transfusion (SPEBT) for pregnant women with sickle cell disease (SCD). The protocol for the randomised feasibility trial assessing SPEBT versus usual care in women with SCD (TAPS2 trial) has previously been published. This publication outlines the statistical and qualitative analysis plan for the study. METHODS AND DESIGN: TAPS2 is a randomised two-arm phase 2 feasibility trial with a nested qualitative study and health economic evaluation...
March 24, 2023: Trials
https://read.qxmd.com/read/36964614/effect-of-lung-ultrasound-guided-fluid-deresuscitation-on-duration-of-ventilation-in-intensive-care-unit-patients-confidence-protocol-for-a-multicentre-randomised-controlled-trial
#4
JOURNAL ARTICLE
Siebe G Blok, Amne Mousa, Michelle G Brouwer, Harm-Jan de Grooth, Ary Serpa Neto, Michiel J Blans, Sylvia den Boer, Tom Dormans, Henrik Endeman, Timo Roeleveld, Harm Scholten, Eline R van Slobbe-Bijlsma, Erik Scholten, Hugo Touw, Fleur Stefanie L I M van der Ven, Evert-Jan Wils, David J van Westerloo, Leo M A Heunks, Marcus J Schultz, Frederique Paulus, Pieter R Tuinman
BACKGROUND: Fluid therapy is a common intervention in critically ill patients. It is increasingly recognised that deresuscitation is an essential part of fluid therapy and delayed deresuscitation is associated with longer invasive ventilation and length of intensive care unit (ICU) stay. However, optimal timing and rate of deresuscitation remain unclear. Lung ultrasound (LUS) may be used to identify fluid overload. We hypothesise that daily LUS-guided deresuscitation is superior to deresuscitation without LUS in critically ill patients expected to undergo invasive ventilation for more than 24 h in terms of ventilator free-days and being alive at day 28...
March 24, 2023: Trials
https://read.qxmd.com/read/36964584/suture-tape-augmentation-of-anterior-cruciate-ligament-reconstruction-a-prospective-randomised-controlled-trial-staclr
#5
JOURNAL ARTICLE
Lachlan Huntington, Andrew Griffith, Libby Spiers, Rebecca Pile, Lachlan Batty, Scott Tulloch, Phong Tran
BACKGROUND: Anterior cruciate ligament (ACL) reconstruction aims to restore anteroposterior and rotatory stability to the knee following ACL injury. This requires the graft to withstand the forces applied during the process of ligamentisation and the rehabilitative period. We hypothesise that the use of suture tape augmentation of single bundle ACL reconstruction (ACLR) will reduce residual knee laxity and improve patient-reported outcomes at 2-year follow-up. We will conduct a 1:1 parallel arm single-centre randomised controlled trial comparing suture tape augmented ACLR to standard ACLR technique...
March 24, 2023: Trials
https://read.qxmd.com/read/36959664/hoppsa-update-changes-in-the-study-protocol-of-hysterectomy-and-opportunistic-salpingectomy-a-registry-based-randomized-controlled-trial
#6
JOURNAL ARTICLE
Annika Idahl, Per Liv, Anna Darelius, Elin Collins, Karin Sundfeldt, Mathias Pålsson, Annika Strandell
BACKGROUND: The HOPPSA trial is a multi-center national registry-based randomized controlled trial to test the safety and effectiveness of performing opportunistic salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer (EOC). The study protocol was first published in January 2019 and is available at https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-018-3083-8 . Here, we report amendments made to the study protocol since commencement of the trial. CHANGES IN METHODS AND ANALYSIS: The primary outcomes analyses have been changed...
March 24, 2023: Trials
https://read.qxmd.com/read/36959627/development-of-core-outcome-sets-of-food-for-special-medical-purposes-designed-for-type-2-diabetes-mellitus-a-study-protocol
#7
JOURNAL ARTICLE
Dongyu Mu, Jie Gong, Yaoyao Wei, Muxi Chen, Jiajie Yu, Liang Du, Wen Hu
BACKGROUND: The Chinese government stipulates all food for special medical purposes (FSMP) designed for specific diseases to be tested in clinical trials before approving it for registration. The process of developing core outcome sets (COSs), the minimum sets of outcomes supposed to be measured and reported, provides an economical and practical option for stakeholders to communicate and cooperate in conducting clinical trials as well as in reporting FSMP outcomes. This study uses type 2 diabetes mellitus (T2DM) as an example to develop COS for clinical trials of FSMP...
March 24, 2023: Trials
https://read.qxmd.com/read/36959672/leukocyte-and-platelet-rich-fibrin-in-cranial-surgery-study-protocol-for-a-prospective-parallel-group-single-blinded-randomized-controlled-non-inferiority-trial-1
#8
JOURNAL ARTICLE
Birgit Coucke, Anaïs Van Hoylandt, Johannes van Loon, Frank Van Calenbergh, Laura Van Gerven, Tom Theys
BACKGROUND: CSF leakage is a major complication after cranial surgery, thus, adequate dural closure must be performed. Commercially available fibrin sealants are currently considered the gold standard for dural closure, but problems have been reported regarding safety, efficacy, and costs. This trial aims to investigate autologous leukocyte- and platelet-rich fibrin (L-PRF) as an alternative to commercially available fibrin sealants. METHODS/DESIGN: This single-blinded, prospective randomized controlled interventional trial aims to demonstrate the non-inferiority of L-PRF compared to commercially available fibrin sealants for dural closure...
March 23, 2023: Trials
https://read.qxmd.com/read/36959662/promoting-mental-health-and-well-being-in-schools-examining-mindfulness-relaxation-and-strategies-for-safety-and-well-being-in-english-primary-and-secondary-schools-study-protocol-for-a-multi-school-cluster-randomised-controlled-trial-inspire
#9
JOURNAL ARTICLE
Daniel Hayes, Anna Moore, Emily Stapley, Neil Humphrey, Rosie Mansfield, Joao Santos, Emma Ashworth, Praveetha Patalay, Eva-Maria Bonin, Sara Evans-Lacko, Bettina Moltrecht, Kirsty Nisbet, Emma Thornton, Aurelie Lange, Paul Stallard, Abigail Thompson, Jan Rasmus Boehnke, Jessica Deighton
There are increasing rates of internalising difficulties, particularly anxiety and depression, being reported in children and young people in England. School-based universal prevention programmes are thought to be one way of helping tackle such difficulties. This paper describes an update to a four-arm cluster randomised controlled trial ( http://www.isrctn.com/ISRCTN16386254 ), investigating the effectiveness of three different interventions when compared to usual provision, in English primary and secondary pupils...
March 23, 2023: Trials
https://read.qxmd.com/read/36959658/effect-of-focused-power-ultrasound-mediated-perirenal-fat-modification-on-primary-hypertension-protocol-of-a-multicenter-randomized-double-blinded-sham-controlled-study
#10
JOURNAL ARTICLE
Menghuan Li, Jing Shi, Yanhui Sheng, Yuqing Zhang, Tingting Wu, Jiaming Yang, Kerui Zhang, Wei Sun, Xiangqing Kong
BACKGROUND: Perirenal fat plays a key role in sustaining pathological high blood pressure. We aim to investigate the efficacy of intervention for perirenal fat mediated by focused power ultrasound (FPU) on primary hypertension. METHODS: A multicenter, randomized, sham-controlled, double-blinded trial will be implemented in 200 participants with mild to moderate hypertension. All enrolled participants will be randomly allocated to perirenal fat modification (PFM) intervention using FPU or sham-procedure at a ratio of 1:1 and will be followed up at 24 h, 14 days, 30 days, and 90 days after the intervention...
March 23, 2023: Trials
https://read.qxmd.com/read/36959617/community-participatory-learning-and-action-cycle-groups-to-reduce-type-2-diabetes-in-bangladesh-d-clare-an-updated-study-protocol-for-a-parallel-arm-cluster-randomised-controlled-trial
#11
JOURNAL ARTICLE
Carina King, Malini Pires, Naveed Ahmed, Kohenour Akter, Abdul Kuddus, Andrew Copas, Hassan Haghparast-Bidgoli, Joanna Morrison, Tasmin Nahar, Sanjit Kumer Shaha, AKAzad Khan, Kishwar Azad, Edward Fottrell
The "Diabetes: Community-led Awareness, Response and Evaluation" (D:Clare) trial aims to scale up and replicate an evidence-based participatory learning and action cycle intervention in Bangladesh, to inform policy on population-level T2DM prevention and control.The trial was originally designed as a stepped-wedge cluster randomised controlled trial, with the interventions running from March 2020 to September 2022. Twelve clusters were randomly allocated (1:1) to implement the intervention at months 1 or 12 in two steps, and evaluated through three cross-sectional surveys at months 1, 12 and 24...
March 23, 2023: Trials
https://read.qxmd.com/read/36949490/patient-tailored-transcranial-direct-current-stimulation-to-improve-stroke-rehabilitation-study-protocol-of-a-randomized-sham-controlled-trial
#12
JOURNAL ARTICLE
Mia Kolmos, Mads Just Madsen, Marie Louise Liu, Anke Karabanov, Katrine Lyders Johansen, Axel Thielscher, Karen Gandrup, Henrik Lundell, Søren Fuglsang, Esben Thade, Hanne Christensen, Helle Klingenberg Iversen, Hartwig Roman Siebner, Christina Kruuse
BACKGROUND: Many patients do not fully regain motor function after ischemic stroke. Transcranial direct current stimulation (TDCS) targeting the motor cortex may improve motor outcome as an add-on intervention to physical rehabilitation. However, beneficial effects on motor function vary largely among patients within and across TDCS trials. In addition to a large heterogeneity of study designs, this variability may be caused by the fact that TDCS was given as a one-size-fits-all protocol without accounting for anatomical differences between subjects...
March 23, 2023: Trials
https://read.qxmd.com/read/36949478/scandinavian-trial-of-uncomplicated-aortic-dissection-therapy-study-protocol-for-a-randomized-controlled-trial
#13
JOURNAL ARTICLE
Claudina Rudolph, Beate Rikken Lindberg, Timothy Resch, Kevin Mani, Patrick Björkman, Elín Hanna Laxdal, Henrik Støvring, Henriette Margrethe Beck, Gunnar Eriksson, Jacob Budtz-Lilly
BACKGROUND: Contemporary management of uncomplicated type B aortic dissections (uTBAD) is based on the acuity and various morphological features. Medical therapy is mandatory, while the risks of early thoracic endovascular aortic repair (TEVAR) are balanced against the potential for rupture, complex surgery, and death. Improved aortic morphology following TEVAR is documented, but evidence for improved overall survival is lacking. The costs and impact on quality of life are also needed...
March 23, 2023: Trials
https://read.qxmd.com/read/36949531/comparing-the-effects-of-smartphone-based-and-face-to-face-pulmonary-rehabilitation-education-on-caregiver-burden-and-quality-of-life-among-the-family-caregivers-of-patients-with-chronic-obstructive-pulmonary-disease-a-randomized-controlled-field-trial
#14
JOURNAL ARTICLE
Mobina Bahadori, Ramin Sami, Shahla Abolhassani, Vajihe Atashi
BACKGROUND: Functional limitation among patients with chronic obstructive pulmonary disorder (COPD) and their dependence on their family caregivers (FCs) can significantly increase caregiver burden (CB) and reduce the quality of life (QOL) among FCs. Education of pulmonary rehabilitation (PR) to FCs is a strategy with potential positive effects on CB. This study was conducted to compare the effects of smartphone-based and face-to-face (FTF) PR education on CB and QOL among the FCs of patients with COPD...
March 22, 2023: Trials
https://read.qxmd.com/read/36949524/a-retrospective-analysis-of-conditional-power-assumptions-in-clinical-trials-with-continuous-or-binary-endpoints
#15
JOURNAL ARTICLE
Julia M Edwards, Stephen J Walters, Steven A Julious
BACKGROUND: Adaptive clinical trials may use conditional power (CP) to make decisions at interim analyses, requiring assumptions about the treatment effect for remaining patients. It is critical that these assumptions are understood by those using CP in decision-making, as well as timings of these decisions. METHODS: Data for 21 outcomes from 14 published clinical trials were made available for re-analysis. CP curves for accruing outcome information were calculated using and compared with a pre-specified objective criteria for original and transformed versions of the trial data using four future treatment effect assumptions: (i) observed current trend, (ii) hypothesised effect, (iii) 80% optimistic confidence limit, (iv) 90% optimistic confidence limit...
March 22, 2023: Trials
https://read.qxmd.com/read/36949485/strengthening-primary-care-for-diabetes-and-hypertension-in-eswatini-study-protocol-for-a-nationwide-cluster-randomized-controlled-trial
#16
JOURNAL ARTICLE
Michaela Theilmann, Ntombifuthi Ginindza, John Myeni, Sijabulile Dlamini, Bongekile Thobekile Cindzi, Dumezweni Dlamini, Thobile L Dlamini, Maike Greve, Harsh Vivek Harkare, Mbuso Hleta, Philile Khumalo, Lutz M Kolbe, Simon Lewin, Lisa-Rufaro Marowa, Sakhile Masuku, Dumsile Mavuso, Marjan Molemans, Nyasatu Ntshalintshali, Nomathemba Nxumalo, Brianna Osetinsky, Christopher Pell, Ria Reis, Fortunate Shabalala, Bongumusa R Simelane, Lisa Stehr, Fabrizio Tediosi, Frank van Leth, Jan-Walter De Neve, Till Bärnighausen, Pascal Geldsetzer
BACKGROUND: Diabetes and hypertension are increasingly important population health challenges in Eswatini. Prior to this project, healthcare for these conditions was primarily provided through physician-led teams at tertiary care facilities and accessed by only a small fraction of people living with diabetes or hypertension. This trial tests and evaluates two community-based healthcare service models implemented at the national level, which involve health care personnel at primary care facilities and utilize the country's public sector community health worker cadre (the rural health motivators [RHMs]) to help generate demand for care...
March 22, 2023: Trials
https://read.qxmd.com/read/36949472/beat-cf-pulmonary-exacerbations-core-protocol-for-evaluating-the-management-of-pulmonary-exacerbations-in-people-with-cystic-fibrosis
#17
JOURNAL ARTICLE
Andre Schultz, Charlie McLeod, Scott Berry, Julie Marsh, Anne McKenzie, Mitch Messer, Jamie Wood, Ben Saville, Adam Jaffe, Sarath Ranganathan, Steve Stick, Peter Wark, Steve Webb, Tom Snelling
BACKGROUND: Cystic fibrosis (CF) is a rare, inherited, life-limiting condition predominantly affecting the lungs, for which there is no cure. The disease is characterized by recurrent pulmonary exacerbations (PEx), which are thought to drive progressive lung damage. Management of these episodes is complex and generally involves multiple interventions targeting different aspects of disease. The emergence of innovative trials and use of Bayesian statistical methods has created renewed opportunities for studying heterogeneous populations in rare diseases...
March 22, 2023: Trials
https://read.qxmd.com/read/36949445/a-multicentre-patient-and-assessor-blinded-non-inferiority-randomised-and-controlled-phase-ii-trial-to-compare-standard-and-torque-teno-virus-guided-immunosuppression-in-kidney-transplant-recipients-in-the-first-year-after-transplantation-ttvguideit
#18
RANDOMIZED CONTROLLED TRIAL
Frederik Haupenthal, Jette Rahn, Fabrizio Maggi, Fanny Gelas, Philippe Bourgeois, Christian Hugo, Bernd Jilma, Georg A Böhmig, Harald Herkner, Michael Wolzt, Konstantin Doberer, Matthias Vossen, Daniele Focosi, Hannes Neuwirt, Miriam Banas, Bernhard Banas, Klemens Budde, Ondrej Viklicky, Paolo Malvezzi, Lionel Rostaing, Joris I Rotmans, Stephan J L Bakker, Kathrin Eller, Daniel Cejka, Alberto Molina Pérez, David Rodriguez-Arias, Franz König, Gregor Bond
BACKGROUND: Immunosuppression after kidney transplantation is mainly guided via plasma tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The plasma load of the non-pathogenic and highly prevalent torque teno virus (TTV) is associated with the immunosuppression of its host. Non-interventional studies suggest the use of TTV load to predict allograft rejection and infection. The primary objective of the current trial is to demonstrate the safety, tolerability and preliminary efficacy of TTV-guided immunosuppression...
March 22, 2023: Trials
https://read.qxmd.com/read/36949443/influence-of-creatine-supplementation-on-muscle-mass-and-strength-after-stroke-icarus-stroke-trial-study-protocol-for-a-randomized-controlled-trial
#19
JOURNAL ARTICLE
Juli Thomaz de Souza, Marcos F Minicucci, Natália C Ferreira, Bertha F Polegato, Marina Politi Okoshi, Gabriel P Modolo, Bethan E Phillips, Philip J Atherton, Kenneth Smith, Daniel Wilkinson, Adam Gordon, Suzana E Tanni, Vladimir Eliodoro Costa, Maria Fernanda P Fernandes, Silméia G Zanati Bazan, Leonardo A M Zornoff, Rodrigo Bazan, Sérgio A Rupp de Paiva, Paula Schmidt Azevedo
BACKGROUND: Stroke is a leading cause of mortality and disability, and its sequelae are associated with inadequate food intake which can lead to sarcopenia. The aim of this study is to verify the effectiveness of creatine supplementation on functional capacity, strength, and changes in muscle mass during hospitalization for stroke compared to usual care. An exploratory subanalysis will be performed to assess the inflammatory profiles of all participants, in addition to a follow-up 90 days after stroke, to verify functional capacity, muscle strength, mortality, and quality of life...
March 22, 2023: Trials
https://read.qxmd.com/read/36945048/incomplete-reporting-of-complex-interventions-a-call-to-action-for-journal-editors-to-review-their-submission-guidelines
#20
LETTER
Mairead Ryan, Tammy Hoffmann, Riikka Hofmann, Esther van Sluijs
Reporting of intervention research has been inadequate for many years. The development and promotion of freely available checklists aims to address this problem by providing researchers with a list of items that require reporting to enable study interpretation and replication. In this commentary, we present evidence from a recent systematic review of 51 randomised controlled trials published 2015-2020 that inadequate intervention reporting remains a widespread issue and that checklists are not being used to describe all intervention components...
March 22, 2023: Trials
journal
journal
41241
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.